Industry Leaders

Jessica Schulte, MD, PhD

Co-Principal Investigator, Neuro-Oncologist

Dr. Schulte is a neuro-oncologist, who specializes in treating patients with primary and metastatic brain tumors, neurofibromatosis, and schwannomatosis.  Dr. Schulte’s clinical focus spans from late adolescence through adulthood, emphasizing personalized care that aligns each patient’s unique tumor biology with a steadfast commitment to maintaining quality of life (QOL) and daily functioning. Her research is deeply invested in molecularly targeted, function-sparing glioma therapies aimed at improving QOL and fostering survivorship in adolescents and young adults (AYA). In addition to participating in several therapeutic clinical trials, she is the global study chair for a long-term outcome study for AYA patients affected by brain and spinal cord tumors, sponsored by the Pediatric Neuro-Oncology Consortium (PNOC). This extensive protocol collects unparalleled data on neurocognition, QOL, and functional independence, extending up to 20 years post-diagnosis. She enjoys engaging with the AYA patient community and has been lucky to help mentor two young adult support groups, which use a novel peer-led support model.  Dr. Schulte is actively engaged with the Society for Neuro-Oncology, helping to shape the 2025 SNO Guidelines for AYA neuro-oncology care and co-chairing the 2026-2027 SNO Special Interest Track for AYA Neuro-Oncology.

Dr. Schulte’s academic journey began at Northwestern University, where she obtained an M.D. and a Ph.D., focusing on cellular migration related to brain development and glioma formation. Following her neurology residency at Columbia University capped with a year as Chief Resident, she completed a neuro-oncology fellowship at UCSF. Dr. Schulte’s career has since evolved through faculty positions at UCSF and UCSD, leading me to NYU Langone, where she proudly directs the Adolescent and Young Adult Neuro-Oncology program at the NYU Langone Brain & Spine Tumor Center. She is also a member of the NYU Comprehensive Neurofibromatosis Center, where she sees adult patients with neurofibromatosis, and schwannomatosis.

More Information